All six of the most critical ICGs that were examined, including CD274, CTLA4, HAVCR2, IDO1, PDCD1, and PDCD1LG2, exhibited a significant positive correlation with the risk scores in glioma samples (Figure 6A). This evidence concerns the gene IDO1 and central nervous system cancer.